Caris Life Sciences, Inc.(CAI)
Life Sciences Tools & Services
Genomic Sequencing & Profiling
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-13 | HALBERT JON Director | Purchase | +68,000 | +5.00%1,428,224 | $14.56 | $990,080 | View SEC filing | |
| 2026-05-12 | Vacirca Jeff L Director | Purchase | +31,050 | +82.82%68,542 | $16.15 | $501,426 | View SEC filing | |
| 2025-12-12 | Power Luke Thomas See Remarks | Sale | -62,250 | -38.47%99,571 | $26.58 | $1,654,461 | View SEC filing | |
| 2025-11-10 | Spetzler David Baxley President | Purchase | +400 | +0.09%460,777 | $23.85 | $9,540 | View SEC filing | |
| 2025-11-10 | Denton John Russel See Remarks | Purchase | +4,184 | +3.25%132,775 | $24.09 | $100,793 | View SEC filing | |
| 2025-06-23 | Denton John Russel See Remarks | Purchase | +7,500 | +6.19%128,591 | $21.00 | $157,500 | View SEC filing | |
| 2025-06-23 | Brille Brian J See Remarks | Purchase | +30,000 | +4.74%662,428 | $21.00 | $630,000 | View SEC filing |
1-7 of 7